Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "69e8b6d9c44d63abc6fde1be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "paroxetine prolonged release tablets ip", "description": "Paroxetine Prolonged Release Tablets IP\n\nWhen dealing with mental health conditions such as depression, anxiety, or panic disorders, choosing the right medication is crucial for long-term stability and improved quality of life. Paroxetine Prolonged Release Tablets IP is a widely prescribed medication that offers controlled, sustained relief for individuals struggling with various mood and anxiety-related disorders.\n\nThis detailed buyer-intent guide is designed to help patients, caregivers, and healthcare buyers understand the uses, benefits, working mechanism, dosage, and important precautions associated with Paroxetine Prolonged Release Tablets IP.\n\nWhat is Paroxetine Prolonged Release Tablets IP?\n\nParoxetine Prolonged Release Tablets IP contains paroxetine, a selective serotonin reuptake inhibitor (SSRI). It is specifically formulated in a prolonged-release (controlled-release) form, which allows the medication to be released gradually in the body over time.\n\nThis ensures:\n\nStable blood levels of the drug\nReduced dosing frequency\nImproved patient compliance\nFewer fluctuations in therapeutic effect\n\nIt is commonly prescribed for managing a range of psychiatric conditions, including depression and anxiety disorders.\n\nHow Does Paroxetine Prolonged Release Tablets IP Work?\n\nParoxetine works by increasing the levels of serotonin, a neurotransmitter in the brain that plays a key role in mood regulation, emotional balance, and mental well-being.\n\nMechanism of Action:\nBlocks the reabsorption (reuptake) of serotonin in the brain\nEnhances serotonin availability between nerve cells\nImproves communication between neurons\nStabilizes mood and reduces anxiety symptoms\nWhy Prolonged Release Matters:\n\nThe prolonged-release formulation ensures a steady release of medication throughout the day, minimizing side effects and maintaining consistent symptom control.\n\nKey Benefits of Paroxetine Prolonged Release Tablets IP\n1. Effective Treatment for Depression\n\nHelps reduce persistent sadness, low energy, and loss of interest in daily activities.\n\n2. Controls Anxiety Disorders\n\nHighly effective in treating generalized anxiety disorder (GAD), social anxiety, and panic disorder.\n\n3. Improves Emotional Stability\n\nSupports better mood regulation and reduces emotional fluctuations.\n\n4. Once-Daily Convenience\n\nThe prolonged-release formula allows for easy once-daily dosing.\n\n5. Better Tolerability\n\nGradual drug release reduces the risk of sudden side effects compared to immediate-release formulations.\n\nCommon Uses of Paroxetine Prolonged Release Tablets IP\n\nThis medication is prescribed for:\n\nMajor depressive disorder (MDD)\nGeneralized anxiety disorder (GAD)\nPanic disorder\nSocial anxiety disorder\nObsessive-compulsive disorder (OCD)\nPost-traumatic stress disorder (PTSD)\n\nIt is also sometimes used for other conditions based on a doctor’s recommendation.\n\nWho Should Consider Buying Paroxetine Prolonged Release Tablets IP?\n\nThis medication may be suitable for:\n\nIndividuals diagnosed with depression or anxiety disorders\nPatients needing long-term psychiatric management\nThose who prefer once-daily medication for better compliance\nIndividuals who experience side effects with immediate-release SSRIs\n\nImportant: This medication should only be used under a doctor’s prescription and supervision.\n\nDosage and Administration\n\nThe dosage of Paroxetine Prolonged Release Tablets IP depends on the condition being treated and the patient’s response.\n\nGeneral Guidelines:\nTypically taken once daily, usually in the morning\nSwallow the tablet whole with water\nDo not crush, chew, or break the tablet\nDosage Tips:\nStart with a lower dose and increase gradually as advised\nTake the medicine at the same time every day\nDo not skip doses or stop suddenly\nPossible Side Effects\n\nLike all medications, Paroxetine Prolonged Release Tablets IP may cause side effects.\n\nCommon Side Effects:\nNausea\nDrowsiness or fatigue\nDry mouth\nDizziness\nSweating\nLess Common but Serious Side Effects:\nSuicidal thoughts (especially in young adults)\nSevere mood changes\nSerotonin syndrome (rare but serious)\nSexual dysfunction\nWeight changes\n\nIf you experience severe or unusual symptoms, seek medical help immediately.\n\nPrecautions and Warnings\n\nBefore starting this medication, consider the following:\n\nMedical Conditions:\nInform your doctor if you have liver or kidney disease\nPatients with a history of seizures should use caution\nAvoid use in individuals with bipolar disorder without supervision\nPregnancy and Breastfeeding:\nUse only if prescribed\nDiscuss potential risks and benefits with your doctor\nDrug Interactions:\n\nParoxetine may interact with:\n\nMonoamine oxidase inhibitors (MAOIs)\nBlood thinners\nOther antidepressants\nAnti-anxiety medications\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\n\nTo maintain effectiveness:\n\nStore in a cool, dry place\nKeep away from direct sunlight\nMaintain temperature below 25°C\nKeep out of reach of children\nBuying Guide: What to Check Before Purchase\n\nWhen purchasing Paroxetine Prolonged Release Tablets IP, ensure the following:\n\nIt is prescribed by a qualified doctor\nThe product is from a trusted pharmaceutical brand\nPackaging is sealed and undamaged\nExpiry date is valid\nPurchased from a licensed pharmacy\n\nFor distributors or bulk buyers, sourcing from reliable manufacturers ensures quality and consistency.\n\nWhy Choose Paroxetine Prolonged Release Tablets IP?\n\nThis medication stands out because of the following:\n\nProven effectiveness in mental health treatment\nControlled-release technology for consistent results\nImproved patient compliance with once-daily dosing\nReduced side effects compared to immediate-release forms\nWidely trusted by healthcare professionals\n\nFor individuals seeking reliable and long-term management of depression and anxiety, this medication is a strong and dependable choice.\n\nFrequently Asked Questions (FAQs)\n1. How long does it take to work?\n\nIt may take 2–4 weeks to notice improvement, with full benefits appearing after several weeks.\n\n2. Can I stop taking it once I feel better?\n\nNo, stopping suddenly can cause withdrawal symptoms. Always consult your doctor.\n\n3. Is it addictive?\n\nNo, but it should be taken as prescribed to avoid dependency-like withdrawal symptoms.\n\n4. Can I take it at night?\n\nIt is usually taken in the morning, but your doctor may adjust timing based on your condition.\n\n5. Does it affect sleep?\n\nIt may cause drowsiness or insomnia in some individuals.\n\nLifestyle Tips for Better Results\n\nTo enhance the effectiveness of Paroxetine:\n\nMaintain a regular sleep schedule\nPractice stress management techniques (yoga, meditation)\nEat a balanced diet\nAvoid alcohol and recreational drugs\nStay physically active\nConclusion\n\nParoxetine Prolonged Release Tablets IP is a highly effective and well-established medication for managing depression, anxiety, and other mental health conditions. Its prolonged-release formulation ensures steady symptom control, improved tolerability, and better patient compliance.\n\nFor best results, always use this medication under medical supervision, follow the prescribed dosage, and combine it with a healthy lifestyle. With the right approach, it can significantly improve emotional well-being and overall quality of life.", "price": 340.0, "discountamount": 102.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2386, "imageuri": "https://productimages.withfloats.com/actual/69e8b716cd1d55c59bd1b04b.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e8b716cd1d55c59bd1b04b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-22T11:54:01.282Z", "updatedon": "2026-05-20T12:03:10.275Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/paroxetine-prolonged-release-tablets-ip/2386", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAROXTIME CR 37.5", "category": "NEUROLOGY RANGE", "tags": [ "paroxetine prolonged release tablets", "paroxetine prolonged release tablets uses", "paroxetine prolonged release tablets ip", "paroxetine prolonged release tablets in hindi", "rx paroxetine prolonged release tablets", "paroxetine prolonged release tablets side effects", "use of paroxetine prolonged release tablets", "Paroxetine Prolonged Release Tablets 37.5 mg", "paroxetine prolonged release tablets 37.5 mg price in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69ba6804c567eee0a8f28929", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin hydrochloride prolonged release and glimepiride tablets", "description": "Managing blood sugar levels effectively is essential for leading a healthy and active life, especially for individuals living with Type 2 Diabetes. With changing lifestyles, unhealthy eating habits, and rising stress levels, diabetes has become increasingly common. To address this, combination therapies like SEIZMET G3 850 offer a powerful and balanced approach to blood sugar control.\n\nThis article provides a detailed, human-friendly, and SEO-optimized guide to Metformin Hydrochloride Prolonged Release and Glimepiride Tablets, marketed under the brand name SEIZMET G3 850.\n\nWhat is SEIZMET G3 850?\n\nSEIZMET G3 850 is a combination anti-diabetic medication that contains:\n\nMetformin Hydrochloride (Prolonged Release) – 850 mg\n\nGlimepiride – 3 mg\n\nThis dual-action formula is designed to control high blood sugar levels in patients with Type 2 Diabetes by targeting different mechanisms in the body.\n\nHow Does SEIZMET G3 850 Work?\n\nThis medicine works through a combination of two powerful components:\n\n1. Metformin (Prolonged Release)\n\nMetformin helps:\n\nReduce glucose production in the liver\n\nImprove insulin sensitivity\n\nEnhance glucose absorption by cells\n\nThe prolonged-release formulation ensures gradual and sustained action, reducing side effects and improving patient compliance.\n\n2. Glimepiride\n\nGlimepiride works by:\n\nStimulating the pancreas to release insulin\n\nImproving the body’s ability to utilize insulin\n\nTogether, these ingredients provide comprehensive blood sugar control throughout the day.\n\nUses of SEIZMET G3 850\n\nSEIZMET G3 850 is primarily used for:\n\n✔ Management of Type 2 Diabetes\n\nIt helps control high blood sugar levels when diet and exercise alone are not sufficient.\n\n✔ Improving Glycemic Control\n\nIt stabilizes blood glucose fluctuations and prevents sudden spikes.\n\n✔ Reducing Risk of Complications\n\nProper diabetes management reduces the risk of:\n\nHeart disease\n\nKidney damage\n\nNerve problems\n\nVision issues\n\nKey Benefits of SEIZMET G3 850\n1. Dual Action Formula\n\nCombines two effective drugs to target diabetes from multiple angles.\n\n2. Sustained Blood Sugar Control\n\nThe prolonged-release metformin ensures steady glucose control throughout the day.\n\n3. Improved Insulin Function\n\nEnhances insulin sensitivity and promotes better glucose utilization.\n\n4. Convenient Dosage\n\nSingle tablet combination reduces pill burden and improves adherence.\n\n5. Weight Neutral Effect\n\nMetformin may help prevent weight gain often associated with diabetes medications.\n\n6. Cardiovascular Protection\n\nHelps reduce the risk of heart-related complications in diabetic patients.\n\nDosage and Administration\n\nAlways take SEIZMET G3 850 as prescribed by your doctor\n\nUsually taken once daily with meals\n\nSwallow the tablet whole—do not crush or chew\n\nMaintain a balanced diet and regular exercise routine\n\nPossible Side Effects\n\nLike all medications, SEIZMET G3 850 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nDizziness\n\nThese are usually mild and improve as your body adjusts to the medication.\n\nSerious Side Effects (Rare but Important):\n\nLow blood sugar (hypoglycemia)\n\nLactic acidosis (a rare but serious condition linked to metformin)\n\nAllergic reactions (rash, swelling, itching)\n\nSeek immediate medical attention if you experience severe symptoms.\n\nPrecautions and Warnings\n\nBefore taking SEIZMET G3 850, inform your doctor if you have:\n\nKidney or liver disease\n\nHeart conditions\n\nHistory of alcohol abuse\n\nVitamin B12 deficiency\n\nImportant Tips:\n\nAvoid excessive alcohol consumption\n\nMonitor blood sugar regularly\n\nFollow a diabetic-friendly diet\n\nInform your doctor about other medications\n\nWho Should Avoid This Medicine?\n\nSEIZMET G3 850 may not be suitable for:\n\nPatients with severe kidney disease\n\nIndividuals with Type 1 Diabetes\n\nPregnant or breastfeeding women (unless prescribed)\n\nPeople with known allergies to its components\n\nLifestyle Tips for Better Results\n\nMedication works best when combined with a healthy lifestyle:\n\n✔ Balanced Diet\nInclude:\nWhole grains\nVegetables\n\nLean protein\n\nAvoid sugary and processed foods.\n\n✔ Regular Exercise\n\nAt least 30 minutes of daily activity helps improve insulin sensitivity.\n\n✔ Stress Management\n\nStress can increase blood sugar levels—practice meditation or yoga.\n\n✔ Routine Checkups\n\nRegular monitoring ensures better control and prevents complications.\n\nWhy Choose the SEIZMET G3 850?\n\nChoosing the right medication is crucial in diabetes management. SEIZMET G3 850 stands out because:\n\nIt combines trusted and proven ingredients\n\nOffers long-lasting glucose control\n\nImproves overall metabolic health\n\nSupports a better quality of life\n\nConclusion\nLiving with type 2 diabetes can be challenging, but with the right treatment and lifestyle choices, it can be effectively managed.", "price": 112.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2338, "imageuri": "https://productimages.withfloats.com/actual/69ba680714005fb7b0e65883.png", "tileimageuri": "https://productimages.withfloats.com/tile/69ba680714005fb7b0e65883.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-18T08:53:24.979Z", "updatedon": "2026-03-18T09:03:56.284Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-prolonged-release-and-glimepiride-tablets/2338", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G3 850", "category": "DIABETIC RANGE", "tags": [ "metformin prolonged release and glimepiride tablets uses", "glimepiride with metformin sr tablets benefits", "metformin hydrochloride pr and glimepiride combination", "metformin sr and glimepiride tablets dosage guide", "glimepiride metformin tablets for type 2 diabetes", "metformin glimepiride combination therapy benefits", "metformin glimepiride tablets for sugar control", "tablets for type 2 diabetes control india", "best medicine for high blood sugar type 2", "combination tablets for diabetes management", "what is metformin hydrochloride prolonged release", "how to control blood sugar with oral tablets", "order metformin glimepiride tablets online india", "glimepiride and metformin tablets manufacturer india", "where to buy diabetes tablets metformin glimepiride", "prescription tablets for type 2 diabetes buy online", "metformin 850 glimepiride 3mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad74702e53c888beeab308d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets", "description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n", "price": 210.0, "discountamount": 147.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2505, "imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:48:34.116Z", "updatedon": "2026-10-20T10:48:34.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 10", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad7442bf24c5a4bbccf4b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets", "description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.", "price": 230.0, "discountamount": 69.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2504, "imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:36:27.325Z", "updatedon": "2026-10-20T10:36:27.325Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 25", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad73c502f1fbe0284e2dcb5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ketorolac Tromethamine Ophthalmic Solution", "description": "CIPVISION KEYPROFEN 0.5 is an ophthalmic formulation containing Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory drug (NSAID) used in specific eye-care situations. It works by reducing the production of prostaglandins, chemical substances that contribute to pain and inflammation. This action may help manage certain inflammatory eye symptoms when the medicine is prescribed for an appropriate condition.\n\nCIPVISION KEYPROFEN 0.5 is intended for topical application to the eyes under the supervision of a qualified healthcare professional. Its suitability depends on the patient's symptoms, clinical diagnosis, and the approved product information.\n\nFor pharmacies, medical distributors, healthcare professionals, and pharmaceutical product catalogues, CIPVISION KEYPROFEN 0.5 represents an ophthalmic product containing a recognised anti-inflammatory ingredient. Appropriate product information helps users understand its intended role, administration requirements, and important precautions.\nComposition of CIPVISION KEYPROFEN 0.5\nThe stated active ingredient in CIPVISION KEYPROFEN 0.5 is:\n\nKetorolac Tromethamine 0.5% w/v: This medicine belongs to the NSAID class. It inhibits cyclooxygenase enzymes involved in the production of prostaglandins, helping reduce inflammatory activity and associated discomfort in suitable ophthalmic conditions.\n\nThe complete formulation, inactive ingredients, pack size, and approved therapeutic indications should be verified using the product packaging and official prescribing information.\nKey Features of CIPVISION KEYPROFEN 0.5 Eye Drops\nCIPVISION KEYPROFEN 0.5 has several important characteristics relevant to ophthalmic care:\n- NSAID-based formulation: Contains Ketorolac Tromethamine, a non-steroidal anti-inflammatory medicine.\n- Inflammation control: Helps manage inflammation in specific eye conditions when prescribed appropriately.\n- Prostaglandin reduction: Acts by inhibiting enzymes involved in the formation of inflammatory mediators.\n- Topical eye application: Designed for administration directly into the eye according to prescribed directions.\n- Clinically guided use: Requires an appropriate diagnosis and advice from an eye-care professional.\nThe potential role of this medicine depends on the underlying eye condition, the approved product indications, and the patient's individual health requirements.\nWhat Is CIPVISION KEYPROFEN 0.5 Used For?\nCIPVISION KEYPROFEN 0.5 may be prescribed for selected eye conditions in which reducing inflammation, itching, or pain is clinically appropriate. The precise indication should be confirmed from the approved product information.\n1. Management of Selected Inflammatory Eye Conditions\nInflammation of the eye may cause redness, irritation, watering, and discomfort. Ketorolac Tromethamine reduces the production of prostaglandins involved in the inflammatory response. An ophthalmologist can determine whether this medicine is suitable after assessing the cause of the symptoms.\n2. Relief of Certain Types of Eye Discomfort\nKetorolac Tromethamine ophthalmic preparations may help relieve ocular pain in approved clinical situations. Some formulations are also indicated for itching associated with seasonal allergic conjunctivitis. These uses depend on the specific product's approved labelling.\n\nPersistent eye pain, redness, or irritation should not be treated through self-medication because these symptoms can arise from infections, injuries, or other conditions requiring different treatment.\n3. Eye Care Following Certain Surgical Procedures\nSome Ketorolac Tromethamine ophthalmic products are used to manage pain and inflammation associated with eye surgery, including cataract procedures. Postoperative treatment must follow the ophthalmologist's instructions because the appropriate medicine, dosage, and duration depend on the procedure and the patient's recovery.\n\nAlways verify whether CIPVISION KEYPROFEN 0.5 is approved for the intended postoperative use before including a specific surgical indication in product information.\nHow Does CIPVISION KEYPROFEN 0.5 Work?\nKetorolac Tromethamine belongs to the non-steroidal anti-inflammatory drug category. Its action involves inhibiting cyclooxygenase (COX) enzymes, which help produce prostaglandins.\n\nProstaglandins participate in inflammatory processes and pain signalling. By reducing their production, Ketorolac Tromethamine can help control inflammation and associated discomfort in certain eye conditions.\n\nUnlike corticosteroids, Ketorolac Tromethamine is a non-steroidal anti-inflammatory medicine. However, it is not appropriate for every eye complaint. It does not treat all causes of eye redness or pain, and suspected infections may require a different treatment approach.\nPotential Benefits of CIPVISION KEYPROFEN 0.5\nWhen prescribed for an appropriate indication, CIPVISION KEYPROFEN 0.5 may offer the following benefits:\n- Anti-inflammatory action: Helps reduce inflammatory activity in selected ophthalmic conditions.\n- Management of eye pain: May relieve pain in specific clinical situations covered by the relevant product indication.\n- Non-steroidal treatment option: Provides an alternative mechanism to corticosteroid-based medicines for appropriate cases.\n- Local administration: Allows the active ingredient to be delivered directly to the eye.\n- Support for ophthalmic treatment: May be included in a treatment plan developed by an eye-care professional.\nThe response to treatment varies according to the diagnosis, severity of the condition, individual health factors, and adherence to the prescribed instructions. The product should not be considered a universal treatment for eye pain or inflammation.\nHow to Use CIPVISION KEYPROFEN 0.5 Eye Drops\nUse CIPVISION KEYPROFEN 0.5 only according to your ophthalmologist's instructions and the product leaflet.\n1. Clean your hands: Wash and dry your hands before handling the eye-drop bottle.\n2. Check the bottle: Confirm the product name, expiry date, and administration instructions before use.\n3. Prevent contamination: Keep the dropper tip away from your eyes, eyelids, fingers, and other surfaces.\n4. Follow the prescribed dosage: Use only the recommended number of drops and the prescribed frequency.\n5. Use other eye medicines carefully: Ask your healthcare professional how much time to leave between different ophthalmic preparations.\n6. Avoid prolonged use: Do not continue treatment longer than recommended, as extended NSAID use may increase the risk of eye complications.\n7. Follow storage instructions: Store the medicine as directed on its packaging and observe any instructions concerning use after opening.\n8. Do not share the bottle: Sharing eye drops can increase the risk of contamination.\n9. Attend follow-up appointments: Follow your ophthalmologist's advice, particularly when using the medicine after eye surgery.\nIf you miss a dose, follow the instructions in the product leaflet or consult your healthcare professional. Do not double the next dose to compensate for a missed application.\nPrecautions and Safety Information\nAlthough Ketorolac Tromethamine eye drops can be useful in appropriate clinical settings, they may cause side effects and require additional caution in certain patients.\nPossible Side Effects\nSome people may experience temporary burning, stinging, irritation, or discomfort after applying the drops. Ophthalmic NSAIDs can also delay healing and, in susceptible individuals, increase the risk of corneal complications. Rare cases of serious corneal damage have been reported.\n\nContact your ophthalmologist if symptoms persist or worsen. Seek urgent medical assessment if you experience severe eye pain, significant changes in vision, marked redness, or other serious symptoms.\nImportant Precautions\n- Corneal conditions: Tell your doctor if you have corneal disease, a damaged eye surface, or delayed healing.\n- Dry eyes: Inform your healthcare professional if you have severe dry eye symptoms or another condition affecting the eye surface.\n- Allergies: Disclose any previous allergic reaction to Ketorolac, aspirin, or other NSAIDs.\n- Bleeding risks: Discuss any bleeding disorder or medicine that may increase bleeding risk.\n- Eye surgery: Follow your surgeon's instructions, as postoperative use requires appropriate monitoring.\n- Pregnancy and breastfeeding: Consult your doctor before using the medicine during pregnancy or while breastfeeding.\n- Other medicines: Inform your healthcare professional about all medicines and eye preparations you currently use.\nCIPVISION KEYPROFEN 0.5 is intended for ophthalmic use only. Keep it out of children's reach and never use it beyond the labelled expiry date.\nWhy Consider CIPVISION KEYPROFEN 0.5 for Pharmaceutical Product Portfolios?\nCIPVISION KEYPROFEN 0.5 combines a distinct pharmaceutical brand identity with Ketorolac Tromethamine 0.5% ophthalmic solution. The formulation may be relevant to product catalogues serving pharmacies, medical distributors, and healthcare professionals involved in ophthalmic care.\n\nClear product information supports responsible pharmaceutical communication by explaining the active ingredient, its mechanism of action, appropriate clinical applications, and safety considerations.\n\nFor accurate product representation, always verify the approved strength, indications, contraindications, dosage, storage requirements, and instructions against the official packaging and prescribing information.\nConclusion\nCIPVISION KEYPROFEN 0.5 Eye Drops contains Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory ingredient used in selected ophthalmic conditions. By inhibiting prostaglandin production, it helps manage inflammation and may relieve pain in specific approved clinical settings.\n\nCorrect administration, appropriate patient selection, and awareness of potential side effects are essential for responsible use. Consult a qualified eye-care professional for treatment guidance and refer to the approved product information for complete details.\nFrequently Asked Questions (FAQs)\n1. What is CIPVISION KEYPROFEN 0.5?\nCIPVISION KEYPROFEN 0.5 is an ophthalmic solution containing Ketorolac Tromethamine 0.5% w/v, according to the composition provided. It is intended for specific eye-care applications under professional guidance.\n2. What is CIPVISION KEYPROFEN 0.5 used for?\nKetorolac Tromethamine ophthalmic preparations may be prescribed for certain inflammatory eye conditions, itching associated with seasonal allergic conjunctivitis, or pain and inflammation following specific eye procedures. The approved uses of CIPVISION KEYPROFEN 0.5 must be confirmed from its official product information.\n3. How does Ketorolac Tromethamine work in the eyes?\nKetorolac Tromethamine inhibits cyclooxygenase enzymes involved in prostaglandin production. This helps reduce inflammatory activity and associated pain in appropriate ophthalmic conditions.\n4. Can CIPVISION KEYPROFEN 0.5 be used without a prescription?\nUse this medicine only under appropriate medical guidance. An eye-care professional should determine whether it is suitable, particularly because NSAID eye drops can affect healing and may cause complications in susceptible patients.\n5. What precautions should be taken while using CIPVISION KEYPROFEN 0.5?\nAvoid contaminating the dropper tip, follow the prescribed dosage, and do not use the drops for longer than recommended. Inform your doctor about corneal problems, allergies to NSAIDs, bleeding disorders, and other medicines you use.\n6. How should CIPVISION KEYPROFEN 0.5 be stored?\nFollow the storage instructions on the product packaging. Keep the container closed as directed, protect it from unsuitable storage conditions, and observe any instructions concerning disposal after opening.\n\n\n", "price": 80.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2503, "imageuri": "https://productimages.withfloats.com/actual/6ad73c52dc6a6c6c9945f376.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad73c52dc6a6c6c9945f376.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:02:56.893Z", "updatedon": "2026-10-20T10:02:56.893Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ophthalmic-solution/2503", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION KEYPROFEN 0.5", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6def248b0777b5cb29791c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Propranolol Hydrochloride Sustained Release Capsules IP", "description": "PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional.\n\nManufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician.\n\nComposition\n\nEach Sustained Release Capsule Contains:\n\nPropranolol Hydrochloride IP – 40 mg\nSustained Release Pellets\nPharmaceutical Excipients – q.s.\nCapsule Shell – Approved pharmaceutical-grade ingredients\n\nDosage Form: Sustained Release Capsules\n\nWhat is PROPASULES LA 40?\n\nPROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations.\n\nIts controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice.\n\nKey Features\nContains Propranolol Hydrochloride Sustained Release IP 40 mg\nAdvanced sustained-release technology for prolonged drug delivery\nSupports once-daily dosing as prescribed\nManufactured using premium pharmaceutical-grade ingredients\nProduced in GMP-compliant manufacturing facilities\nStringent quality assurance for consistent product performance\nReliable formulation for long-term therapeutic use under medical supervision\nTherapeutic Uses\n\nHealthcare professionals may prescribe PROPASULES LA 40 for the management of several cardiovascular and neurological disorders, including:\n\nHypertension (high blood pressure)\nChronic stable angina\nCardiac arrhythmias\nPrevention of migraine attacks\nEssential tremor\nPhysical symptoms associated with anxiety\nCardiovascular manifestations of hyperthyroidism\nSecondary prevention following myocardial infarction, when clinically indicated\n\nThe choice of treatment, dosage, and duration should always be individualized based on the patient's medical condition and physician's assessment.\n\nHow PROPASULES LA 40 Works\n\nPropranolol Hydrochloride works by blocking beta-adrenergic receptors located in the heart and other tissues. This action reduces the effects of adrenaline and other stress hormones on the cardiovascular system.\n\nAs a result, the medicine may help:\n\nSlow the heart rate\nReduce the workload on the heart\nLower elevated blood pressure\nImprove control of certain abnormal heart rhythms\nReduce the frequency of migraine episodes\nMinimize symptoms associated with essential tremor\nRelieve physical manifestations of anxiety, such as rapid heartbeat and trembling\n\nThe sustained-release pellets gradually release the medication throughout the day, providing prolonged therapeutic coverage and reducing fluctuations in drug levels.\n\nBenefits of the Sustained Release Formulation\n\nThe advanced sustained-release technology offers several advantages:\n\nControlled and gradual release of the active ingredient\nExtended therapeutic effect throughout the dosing interval\nMore consistent blood concentrations of the medication\nReduced peak-to-trough fluctuations compared with immediate-release formulations\nConvenient dosing schedule that may improve treatment adherence\nSuitable for long-term therapy under medical supervision\n\nTreatment outcomes depend on individual patient response and adherence to the prescribed regimen.\n\nDosage and Administration\n\nTake PROPASULES LA 40 exactly as instructed by your healthcare provider.\n\nGeneral recommendations include:\n\nSwallow the capsule whole with sufficient water.\nDo not crush, chew, or open the capsule unless specifically advised.\nTake the medicine at the same time every day.\nFollow the prescribed dosage schedule carefully.\nDo not discontinue treatment abruptly without consulting your physician, as sudden withdrawal may increase the risk of cardiovascular complications.\nPossible Side Effects\n\nLike all medications, PROPASULES LA 40 may cause side effects in some individuals, although many patients tolerate it well.\n\nCommon side effects may include:\n\nFatigue\nDizziness\nSlow heartbeat\nCold hands and feet\nNausea\nSleep disturbances\nMild stomach discomfort\n\nSeek immediate medical attention if you experience breathing difficulty, severe dizziness, fainting, swelling of the face or throat, or signs of a serious allergic reaction.\n\nConsult your healthcare provider if any side effects persist or become troublesome.\n\nPrecautions and Warnings\n\nBefore starting PROPASULES LA 40, inform your doctor if you have:\n\nAsthma or chronic obstructive pulmonary disease (COPD)\nDiabetes mellitus\nLiver impairment\nKidney disease\nHeart failure\nLow blood pressure\nBradycardia (slow heart rate)\nPeripheral vascular disease\nThyroid disorders\nHistory of hypersensitivity reactions\n\nYour physician should also be informed about all prescription medicines, over-the-counter drugs, herbal supplements, and dietary products you are taking to minimize the risk of drug interactions.\n\nPregnancy and Breastfeeding\n\nThe use of PROPASULES LA 40 during pregnancy or breastfeeding should only be considered when recommended by a qualified healthcare professional after carefully evaluating the potential benefits and possible risks.\n\nAlways consult your physician before taking this medicine during pregnancy or while nursing.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from moisture and direct sunlight.\nKeep below the storage temperature specified on the product label.\nStore in the original packaging until use.\nKeep out of the reach of children.\nDo not use the medicine after the expiry date printed on the pack.\nWhy Choose PROPASULES LA 40?\n\nPROPASULES LA 40 is formulated to deliver dependable therapeutic performance through advanced sustained-release technology. Manufactured under stringent pharmaceutical quality standards, it combines consistent drug delivery, convenient dosing, and reliable product quality to support long-term cardiovascular and neurological care.\n\nKey Advantages\n\nPremium sustained-release Propranolol formulation\nControlled drug release for prolonged therapeutic action\nConvenient once-daily administration as prescribed\nManufactured in GMP-certified facilities\nHigh standards of quality, purity, and consistency\nReliable formulation for chronic disease management\nFrequently Asked Questions (FAQs)\nWhat is PROPASULES LA 40 prescribed for?\n\nPROPASULES LA 40 may be prescribed for conditions such as hypertension, chronic angina, cardiac arrhythmias, migraine prevention, essential tremor, anxiety-related physical symptoms, and certain cardiovascular conditions, depending on the physician's evaluation.\n\nCan PROPASULES LA 40 be taken once a day?\n\nYes. The sustained-release formulation is designed to support convenient once-daily dosing when prescribed by a healthcare professional.\n\nCan I stop taking PROPASULES LA 40 suddenly?\n\nNo. Abrupt discontinuation of propranolol may increase the risk of serious cardiovascular events. Always consult your doctor before stopping treatment.\n\nCan people with diabetes take PROPASULES LA 40?\n\nPatients with diabetes should use this medicine only under medical supervision, as beta-blockers may mask some warning signs of low blood sugar.\n\nIs PROPASULES LA 40 suitable for every patient?\n\nNo. This medicine may not be appropriate for individuals with certain conditions such as severe asthma, significant bradycardia, or specific cardiac disorders. Your healthcare provider will determine whether it is suitable for your individual medical needs.", "price": 45.0, "discountamount": 14.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2490, "imageuri": "https://productimages.withfloats.com/actual/6a6def271f223d84dee2d962.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6def271f223d84dee2d962.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T13:05:40.676Z", "updatedon": "2026-08-01T13:05:40.676Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//propranolol-hydrochloride-sustained-release-capsules-ip/2490", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PROPASULES LA 40", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dec4d7747964c2eea9a0f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metoprolol Succinate & Hydrochlorthiazide Extended Release Tablets", "description": "METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing.\n\nManufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels.\n\nComposition\n\nBrand Name: METAPROLATE H 50/12.5\n\nGeneric Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets\n\nEach Extended Release Tablet Contains:\n\nMetoprolol Succinate Extended Release – 50 mg\nHydrochlorothiazide – 12.5 mg\n\nDosage Form: Extended Release Tablets\n\nTherapeutic Category: Antihypertensive Medication\n\nWhat is METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management.\n\nMetoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure.\n\nTogether, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice.\n\nUses of METAPROLATE H 50/12.5\n\nHealthcare professionals may prescribe METAPROLATE H 50/12.5 for:\n\nManagement of essential hypertension\nPatients requiring combination antihypertensive therapy\nLong-term maintenance of healthy blood pressure levels\nReducing cardiovascular risks associated with uncontrolled hypertension\nSupporting comprehensive blood pressure management alongside lifestyle modifications\n\nThis medicine should always be used under the supervision of a qualified healthcare professional.\n\nBenefits of METAPROLATE H 50/12.5\nDual-Action Blood Pressure Control\n\nThe combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction.\n\nSustained Drug Release\n\nThe extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control.\n\nConvenient Once-Daily Administration\n\nA single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy.\n\nSupports Cardiovascular Health\n\nMaintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time.\n\nManufactured to High Quality Standards\n\nEvery batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency.\n\nHow METAPROLATE H 50/12.5 Works\n\nThe effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients.\n\nMetoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps:\n\nSlow the heart rate\nReduce the force of cardiac contractions\nDecrease oxygen demand by the heart\nLower blood pressure\n\nHydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps:\n\nReduce circulating blood volume\nMinimize fluid retention\nLower blood pressure\nImprove overall cardiovascular function\n\nTogether, these mechanisms contribute to effective and sustained blood pressure management.\n\nDosage and Administration\n\nTake METAPROLATE H 50/12.5 exactly as prescribed by your physician.\n\nGeneral recommendations include:\n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the extended-release tablet whole with water.\nDo not crush, chew, or split the tablet unless specifically instructed.\nIt may be taken with or without food according to your doctor's advice.\nTake the medication at the same time each day to maintain consistent therapeutic levels.\nContinue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise.\nPossible Side Effects\n\nAs with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well.\n\nCommonly reported side effects include:\n\nDizziness\nTiredness or fatigue\nSlow heartbeat\nHeadache\nIncreased urination\nNausea\nLow blood pressure\nChanges in electrolyte levels\n\nSeek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms.\n\nConsult your healthcare provider if any side effect persists or becomes troublesome.\n\nPrecautions and Warnings\n\nBefore starting METAPROLATE H 50/12.5, inform your healthcare provider if you have:\n\nHeart rhythm abnormalities\nHeart failure\nAsthma or chronic respiratory disorders\nDiabetes mellitus\nKidney or liver impairment\nGout\nElectrolyte imbalance\nThyroid disorders\nAllergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product\n\nRegular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from excessive heat, moisture, and direct sunlight.\nKeep the tablets in their original packaging until use.\nStore at the temperature indicated on the product label.\nKeep out of the reach of children.\nWhy Choose METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care.\n\nKey Advantages\n\nExtended-release formulation for sustained therapeutic action\nCombination of two proven antihypertensive medicines\nConvenient once-daily dosing\nHigh-quality manufacturing with strict quality assurance\nReliable efficacy and consistent product performance\nSuitable for long-term hypertension management under medical supervision\nFrequently Asked Questions (FAQs)\nWhat is METAPROLATE H 50/12.5 prescribed for?\n\nIt is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy.\n\nHow does the extended-release formulation benefit patients?\n\nThe extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control.\n\nCan I discontinue METAPROLATE H 50/12.5 on my own?\n\nNo. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment.\n\nCan this medicine be used with other antihypertensive medications?\n\nYour doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals.\n\nHow long should treatment continue?\n\nHypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.", "price": 248.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2488, "imageuri": "https://productimages.withfloats.com/actual/6a6dec4fc0246085c8f72513.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6dec4fc0246085c8f72513.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T12:53:33.409Z", "updatedon": "2026-08-01T12:53:33.409Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metoprolol-succinate-hydrochlorthiazide-extended-release-tablets/2488", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE H 50/12.5", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a68576d4f0b0886fc04ae84", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Prednisolone Acetate Ophthalmic Suspension USP", "description": "Prednisolone Acetate Ophthalmic Suspension USP is a prescription corticosteroid eye drop formulated to reduce inflammation, redness, swelling, and discomfort associated with various eye conditions. It is commonly prescribed by ophthalmologists after eye surgery or for inflammatory eye disorders that respond to steroid treatment.\n\nThis ophthalmic suspension works by suppressing the body's inflammatory response, helping relieve symptoms such as eye pain, irritation, and light sensitivity while supporting the healing process. Because it is a prescription medicine, it should only be used under the supervision of a qualified healthcare professional.\n\nWhether you are a healthcare provider, pharmacy, hospital, or licensed distributor, choosing a reliable source for Prednisolone Acetate Ophthalmic Suspension USP ensures consistent quality, regulatory compliance, and patient safety.\n\nWhat Is Prednisolone Acetate Ophthalmic Suspension USP?\nPrednisolone Acetate Ophthalmic Suspension USP is a sterile corticosteroid eye suspension intended for ophthalmic use. It is designed to treat steroid-responsive inflammation affecting the anterior segment of the eye when bacterial, viral, or fungal infections have been ruled out or are being appropriately managed.\n\nDoctors may prescribe this medication for conditions including:\n\nPost-operative eye inflammation\nAllergic eye inflammation\nUveitis\nIritis\nCertain inflammatory eye disorders\nCorneal or conjunctival inflammation that responds to corticosteroids\nAlways use this medication exactly as directed by your eye care specialist.\n\nHow Does Prednisolone Acetate Ophthalmic Suspension USP Work?\nPrednisolone acetate belongs to the corticosteroid class of medicines. It works by reducing the release of inflammatory substances that cause swelling, redness, pain, and irritation within the eye.\n\nBy controlling inflammation, the medication helps:\n\nReduce eye redness\nMinimize swelling\nRelieve discomfort\nImprove patient comfort during recovery\nSupport healing following eye procedures\nThe suspension should be shaken well before each use to ensure even distribution of the active ingredient.\n\nKey Benefits\nPrednisolone Acetate Ophthalmic Suspension USP offers several important benefits when prescribed appropriately:\n\nHelps reduce eye inflammation quickly\nRelieves redness and swelling\nSupports recovery after ophthalmic surgery\nReduces eye discomfort and irritation\nSterile ophthalmic formulation\nSuitable for professional ophthalmic treatment plans\nManufactured according to pharmaceutical quality standards\nIndications\nYour healthcare provider may recommend Prednisolone Acetate Ophthalmic Suspension USP for:\n\nEye inflammation after cataract surgery\nSteroid-responsive conjunctival inflammation\nCorneal inflammation\nUveitis\nIritis\nAllergic inflammatory eye conditions\nOther ophthalmic inflammatory disorders as determined by an eye specialist\nThis medication should not be used without a prescription.\n\nDirections for Use\nUse Prednisolone Acetate Ophthalmic Suspension USP only as prescribed.\n\nGeneral instructions include:\n\nWash your hands before application.\nShake the bottle well.\nTilt your head back.\nInstill the prescribed number of drops into the affected eye.\nAvoid touching the dropper tip to any surface.\nClose the bottle tightly after use.\nFollow the complete treatment schedule even if symptoms improve.\nDo not stop treatment suddenly unless advised by your healthcare provider.\n\nPrecautions\nBefore using Prednisolone Acetate Ophthalmic Suspension USP, inform your doctor if you:\n\nHave glaucoma\nHave a viral, fungal, or bacterial eye infection\nWear contact lenses\nAre pregnant or breastfeeding\nHave recently undergone eye surgery\nAre allergic to corticosteroids\nLong-term or excessive use may increase the risk of elevated intraocular pressure, cataracts, or secondary eye infections. Regular eye examinations may be recommended during extended treatment.\n\nPossible Side Effects\nLike all medicines, Prednisolone Acetate Ophthalmic Suspension USP may cause side effects.\n\nCommon side effects may include:\n\nTemporary blurred vision\nMild burning or stinging\nEye irritation\nWatery eyes\nLess common but more serious effects may include:\n\nIncreased eye pressure\nDelayed wound healing\nCataract formation with prolonged use\nSecondary eye infections\nVision changes\nSeek prompt medical attention if you experience severe eye pain, sudden vision changes, significant redness, or signs of an allergic reaction.\n\nStorage Instructions\nStore Prednisolone Acetate Ophthalmic Suspension USP according to the instructions on the product label.\n\nGeneral recommendations include:\n\nStore at controlled room temperature.\nKeep the bottle tightly closed.\nProtect from excessive heat and direct sunlight.\nDo not freeze unless instructed by the manufacturer.\nKeep out of reach of children.\nDiscard the bottle after the recommended period following opening, as advised by your pharmacist or healthcare provider.\n\nWhy Choose Our Prednisolone Acetate Ophthalmic Suspension USP?\nWe are committed to supplying quality pharmaceutical products that meet applicable manufacturing standards. Our products are carefully handled to help maintain product integrity throughout storage and distribution.\n\nWe offer:\n\nHigh-quality pharmaceutical products\nSecure packaging\nReliable supply\nBulk order support\nTimely delivery\nResponsive customer assistance\nFor product specifications, availability, and ordering information, please contact our sales team.\n\nFrequently Asked Questions (FAQs)\n1. What is Prednisolone Acetate Ophthalmic Suspension USP used for?\nIt is used to treat steroid-responsive inflammation of the eye, including inflammation following eye surgery and certain inflammatory eye conditions, when prescribed by a healthcare professional.\n\n2. Is Prednisolone Acetate Ophthalmic Suspension USP an antibiotic?\nNo. It is a corticosteroid that reduces inflammation. It does not treat bacterial infections.\n\n3. Do I need a prescription?\nYes. Prednisolone Acetate Ophthalmic Suspension USP should only be used under the guidance of a licensed healthcare provider.\n\n4. How long should I use these eye drops?\nThe duration of treatment depends on your diagnosis and your doctor's recommendation. Do not discontinue treatment without medical advice.\n\n5. Should I shake the bottle before use?\nYes. As an ophthalmic suspension, the bottle should be shaken well before each application to ensure the medication is evenly mixed.\n\n6. Can I wear contact lenses while using Prednisolone Acetate Ophthalmic Suspension USP?\nYour eye care professional may advise you to avoid wearing contact lenses during treatment, especially if your eyes are inflamed or recovering from surgery.\n\n7. What happens if I miss a dose?\nUse the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not use extra medication to make up for a missed dose.\n\n8. Can these eye drops cause blurred vision?\nTemporary blurred vision may occur immediately after application. Wait until your vision clears before driving or operating machinery.\n\n9. Are there any serious side effects?\nLong-term use may increase the risk of elevated intraocular pressure, cataracts, delayed healing, or secondary infections. Regular follow-up appointments are important if prolonged treatment is required.\n\n10. How should Prednisolone Acetate Ophthalmic Suspension USP be stored?\nStore it according to the product labeling, keep the bottle tightly closed, protect it from excessive heat and light, and keep it out of the reach of children.\n\n11. Can children use Prednisolone Acetate Ophthalmic Suspension USP?\nUse in children should only occur when prescribed and monitored by a qualified healthcare professional.\n\n12. Can I use Prednisolone Acetate Ophthalmic Suspension USP for red eyes without consulting a doctor?\nNo. Red eyes can have many causes, including infections that may worsen with corticosteroid treatment. Always consult an eye care professional before using steroid eye drops.\n\nIf you're targeting SEO for a pharmaceutical manufacturer, wholesaler, or exporter, I can also tailor this page for commercial/B2B intent while keeping it medically responsible and aligned with search quality guidelines.\n", "price": 62.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2485, "imageuri": "https://productimages.withfloats.com/actual/6a685772440c6b3927c66b54.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685772440c6b3927c66b54.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:17:01.827Z", "updatedon": "2026-07-28T07:17:01.827Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//prednisolone-acetate-ophthalmic-suspension-usp/2485", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION PREDNISOLONE 1%", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
prolonged treatment?

Still searching for
prolonged treatment?

Chat with us